Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated May 9, 2017 (9 years ago)

Benzonatate capsules

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.

Cause type: Stability / shelf life

The product degraded or failed stability testing before its labeled expiry. Heat, moisture or time can break the drug down into degradants or reduce potency. All stability / shelf life recalls.

What was recalled

Benzonatate capsules, 200 mg, 100-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bangaluru -560076 India, Distributed by Strides Pharma Inc East Brunswick, NJ 08816, NDC 64380-713-06

Affected NDC 64380-0713-06

Compare with the code on your package — it is the most precise check available.

Drug: Benzonatate

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Benzonatate
NDC 64380-0713
200 mg/1 Capsule
Oral
Strides Pharma Science Limited Rx
Recalling firm
Strides Pharma INC
NDC code
64380-713-06
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0858-2017 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Benzonatate recalls

See all
Class III · Low risk

Benzonatate Capsules

Superpotent drug: Assay results were slightly above specification at the time zero point.

Ongoing Wrong potency / content Amerisource Health Services LLC NDC 68084-214-01 D-0257-2024
Class I · High risk

Benzonatate capsules

Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg capsules.

Terminated Labeling / mix-up Calvin Scott & Company, Inc. NDC 67877-0573-05 D-1124-2022
Class II · Moderate risk

Benzonatate Capsules

Failed Tablet/Capsule Specifications; recall initiated by manufacturer due to reports of wet capsules

Terminated Failed specification American Health Packaging NDC 68084-214-01 D-0430-2015
Class II · Moderate risk

Benzonatate Capsules

Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.

Terminated Failed specification Zydus Pharmaceuticals USA Inc NDC 68382-247-01 D-0325-2015
Class II · Moderate risk

Benzonatate Capsules

Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.

Terminated Failed specification Zydus Pharmaceuticals USA Inc NDC 68382-248-01 D-0299-2015

Other recalls by Strides Pharma INC

All 2017 recalls